큐어버스
Seoul, KR · 1 known investors
Find your way into 큐어버스
Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.
Founders & leadership
JC
Jungwook ChininFounder
Investors · 1
Frequently asked questions
- What does 큐어버스 do?
- Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.
- Who founded 큐어버스?
- 큐어버스 was founded by Jungwook Chin.
- Who are 큐어버스's investors?
- 큐어버스's investors include Solidus Investment.
- Where is 큐어버스 headquartered?
- 큐어버스 is headquartered in Seoul, KR.